174884-49-2

Upstream product

• 118-58-1 benzyl salicylate 
• 2969-81-5 Ethyl 4-bromobutyrate 

Downstream Products

• 219745-30-9 4-(2-{4-[3-Bromo-1-(4-isobutyl-phenyl)-propoxy]-phenylcarbamoyl}-phenoxy)-butyric acid ethyl ester 
• 219745-29-6 4-(2-{4-[3-Bromo-1-(4-ethyl-phenyl)-propoxy]-phenylcarbamoyl}-phenoxy)-butyric acid ethyl ester 
• 219745-27-4 4-{2-[4-(3-Bromo-1-phenyl-propoxy)-phenylcarbamoyl]-phenoxy}-butyric acid ethyl ester 
• 219745-28-5 4-{2-[4-(3-Bromo-1-p-tolyl-propoxy)-phenylcarbamoyl]-phenoxy}-butyric acid ethyl ester 
• 219745-26-3 4-[2-(4-Hydroxy-phenylcarbamoyl)-phenoxy]-butyric acid ethyl ester 

Relevant academic research and scientific papers

Synthesis and evaluation of novel dual BRD4/HDAC inhibitors

Epigenetic regulation of gene expression via histone acetylation modulates many cellular processes, including apoptosis, the cell cycle, cell growth and differentiation, and inhibitors are promising drug candidates. We have previously developed inhibitors

Synthesis of benzanilide derivatives as dual acting agents with α1- adrenoceptor antagonistic action and steroid 5-α reductase inhibitory activity

Synthesis of benzanilide derivatives which have dual α1-adrenoceptor antagonistic action and steroid 5α-reductase inhibitory activity and their structure-activity relationships is described.